CliffBio
biologic

N/A

Albumin (Human)

Loss of exclusivityOctober 2018projected — 12-year biologic exclusivity estimate
CompanyOctapharma Pharmazeutika Produktionsges.m.b.H.

Drug detail

Brand nameN/A
Active ingredientAlbumin (Human)
Strength25G/500ML
Dosage formInjection
RouteIntravenous
ModalityBiologic
FDA approvalOctober 2006
Marketing statusRx

More from Octapharma Pharmazeutika Produktionsges.m.b.H.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

N/A patent cliff — loss of exclusivity October 2018 | CliffBio